ArticleBMC pulmonary medicine2025
Hospitalization and survival following early vs. late percutaneous tracheostomy under bronchoscopic guidance: a retrospective analysis of 207 cases.
Article in BMC pulmonary medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTracheostomy is a commonly performed procedure for patients requiring prolonged mechanical ventilation. It can be performed at the bedside using percutaneous dilatational tracheostomy (PDT) under bronchoscopic guidance (BG), which reduces the need for surgical tracheostomies. The aim of this study was to compare early versus late BG-PDT in terms of complications and survival.
methodsThis retrospective study included patients who underwent BG-PDT between 2012 and 2022 at the Pulmonary Institute of Rabin Medical Center. Data was collected by reviewing demographic and clinical parameters from electronic medical records, with a minimum follow-up of 24 months after the BG-PDT procedure. Early BG-PDT was defined as a procedure performed within 7 days of intubation and late PDT was performed from day 8 onward.
resultsA total of 207 BG- PDT procedures were performed between 2012 and 2022, of which 188 patients were included in the final analysis. The mean age of the patients was 69 years, with 57.5% being male. Patients who underwent early BG-PDT were younger (mean age 63 vs. 71, p < 0.01).The most common indications for PDT were respiratory disorders (47.8%) and neurological disorders (19.1%). Patients in the early PDT group had a median overall hospitalization duration of 14 days post BG-PDT (IQR 21-31), compared to 33.5 days (IQR 26-47) in the late group (p < 0.01). The overall 1-year survival rate was 54.3% in the early BG-PDT group versus 30.1% in the late BG-PDT group (p = 0.04). The overall 3-year survival for both groups was 24.2%, with 45.4% in the early BG-PDT group and 19.6% in the late BG-PDT group (p = 0.008). Younger age was found to correlate better survival (OR 1.05, 95% CI: 1.02-1.08, p < 0.001) and a higher one-year (54.3% vs. 30%, p = 0.04) and 3-year survival rate of 45.4% in the early vs. 19.6% in the late (p = 0.008).
conclusionsBronchoscopy guided percutaneous dilatational tracheostomy is associated with shorter hospitalization duration and has possible survival advantages when performed within 7 days of intubation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.